Download Leukaemia Section inv(19)(p13q13) TCF3/TFPT, t(19;19)(p13;q13) TCF3/TFPT Atlas of Genetics and Cytogenetics

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Promoter (genetics) wikipedia , lookup

Cell-penetrating peptide wikipedia , lookup

Secreted frizzled-related protein 1 wikipedia , lookup

Protein adsorption wikipedia , lookup

Protein moonlighting wikipedia , lookup

RNA-Seq wikipedia , lookup

Gene expression wikipedia , lookup

Gene expression profiling wikipedia , lookup

Transcriptional regulation wikipedia , lookup

Molecular evolution wikipedia , lookup

Signal transduction wikipedia , lookup

Paracrine signalling wikipedia , lookup

Endogenous retrovirus wikipedia , lookup

X-inactivation wikipedia , lookup

Silencer (genetics) wikipedia , lookup

Protein–protein interaction wikipedia , lookup

Vectors in gene therapy wikipedia , lookup

Artificial gene synthesis wikipedia , lookup

Two-hybrid screening wikipedia , lookup

Gene regulatory network wikipedia , lookup

List of types of proteins wikipedia , lookup

Transcript
Atlas of Genetics and Cytogenetics
in Oncology and Haematology
OPEN ACCESS JOURNAL AT INIST-CNRS
Leukaemia Section
Short Communication
inv(19)(p13q13) TCF3/TFPT, t(19;19)(p13;q13)
TCF3/TFPT
Jean-Loup Huret
Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France
(JLH)
Published in Atlas Database: September 2008
Online updated version : http://AtlasGeneticsOncology.org/Anomalies/t1919p13q13ID1295.html
DOI: 10.4267/2042/44564
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence.
© 2009 Atlas of Genetics and Cytogenetics in Oncology and Haematology
Protein
Role in cell cycle inhibition and apoptosis.
Clinics and pathology
Disease
Result of the chromosomal
anomaly
Childhood pre-B cell acute lymphoblastic leukemia.
Note
There is no clinical data in the only paper describing
the fusion TCF3-TFPT, nor cytogenetic indications
(Brambillasca et al., 1999); inv(19)(p13q13) has also
be found in 3 cases of hairy cell leukemia (Haglund et
al., 1994); the genes involved in these three patients are
unknown; this inv(19) is likely to represent another
entity.
Hybrid gene
Description
5' TCF3 - 3' TFPT; the translocation joins TCF3 exon
13 or 14 to part of TFPT; the junction is in frame in
some cases, and out of frame in others. The reciprocal
transcript was not found.
Fusion protein
Cytogenetics
Description
Variable junction between TCF3 and TFPT, retaining
the transactivation domain of TCF3, but with a
truncation in TFPT, due to the frequent occurrence of a
stop codon.
Cytogenetics morphological
This chromosome rearrangement is cryptic.
Genes involved and proteins
References
TCF3
Location
19p13.3
Protein
TCF3, better known as E2A, is a member of the basic
helix-loop-helix (bHLH) 1 family of transcription
factors that are ubiquitously expressed during
development.
Haglund U, Juliusson G, Stellan B, Gahrton G. Hairy cell
leukemia is characterized by clonal chromosome abnormalities
clustered to specific regions. Blood. 1994 May 1;83(9):2637-45
Brambillasca F, Mosna G, Colombo M, Rivolta A, Caslini C,
Minuzzo M, Giudici G, Mizzi L, Biondi A, Privitera E.
Identification of a novel molecular partner of the E2A gene in
childhood leukemia. Leukemia. 1999 Mar;13(3):369-75
This article should be referenced as such:
TFPT
Huret JL. inv(19)(p13q13) TCF3/TFPT, t(19;19)(p13;q13)
TCF3/TFPT. Atlas Genet Cytogenet Oncol Haematol. 2009;
13(9):670.
Location
19q13.4
Atlas Genet Cytogenet Oncol Haematol. 2009; 13(9)
670